Cart
sales@molnova.com
3',4'-Anhydrovinblastine
CAS No. 38390-45-3
3',4'-Anhydrovinblastine( —— )
Catalog No. M18500 CAS No. 38390-45-3
3', 4'-Anhydrovinblastine is an antineoplastic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 36 | Get Quote |
|
| 25MG | 58 | Get Quote |
|
| 50MG | 86 | Get Quote |
|
| 100MG | 138 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name3',4'-Anhydrovinblastine
-
NoteResearch use only, not for human use.
-
Brief Description3', 4'-Anhydrovinblastine is an antineoplastic agent.
-
Description3', 4'-Anhydrovinblastine is an antineoplastic agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number38390-45-3
-
Formula Weight792.96
-
Molecular FormulaC46H56N4O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCC1=C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Goodbody A, et al. The coupling of catharanthine and vindoline to form 3',4'-anhydrovinblastine by haemoproteins and haemin.[J]. Planta Medica, 1988, 54(03):210-214.
molnova catalog
related products
-
Flindersine
Flindersine
-
α-D-Glucose 1-phosph...
α-D-Glucose 1-phosphate disodium salt is converted into D-glucose-6-phosphate by the enzyme phosphoglucomutase.
-
Nogo-66 (1-40)
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.
